智通财经APP讯，健康之路(02587)发布截至2024年12月31日止年度业绩，收入12.01亿元，同比减少3.51%;经调整净利润2276.4万元;毛利3.66亿元;毛利率30.5%。
企业服务及数字营销服务的毛利由2023年的2.692亿元增加至2024年的2.959亿元，主要是由于随着我们的RWS支持服务进一步发展及扩展，交付的每份真实世界研究(“RWS”)报告及脱敏样本平均成本减少，导致内容服务(尤其是RWS支持服务)的毛利率上升。
更多港股重磅资讯，下载智通财经app
更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.